The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124840022 12484002 2 F 20151003 20160627 20160621 20160708 EXP GB-SA-2016SA111080 AVENTIS 70.00 YR E F Y 0.00000 20160708 CN GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124840022 12484002 1 PS LEFLUNOMIDE. LEFLUNOMIDE 1 Oral 10 MG, ON MONDAYS, WEDNESDAYS AND FRIDAYS Y UNKNOWN 20905 10 MG FILM-COATED TABLET /cycle
124840022 12484002 2 SS LEFLUNOMIDE. LEFLUNOMIDE 1 Oral FOUR TIMES A WEEK Y UNKNOWN 20905 10 MG FILM-COATED TABLET /cycle
124840022 12484002 3 SS ENBREL ETANERCEPT 1 Subcutaneous 50 MG, WEEKLY?SOLUTION FOR INJECTION IN PRE-FILLED PEN Y L76737 0 50 MG SOLUTION FOR INJECTION /wk
124840022 12484002 4 SS ENBREL ETANERCEPT 1 Subcutaneous SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE Y M72573 0 50 MG SOLUTION FOR INJECTION /wk
124840022 12484002 5 C ADCAL CALCIUM CARBONATE 1 Unknown 0
124840022 12484002 6 C CANDESARTAN CANDESARTAN 1 Unknown 0
124840022 12484002 7 C CELEBREX CELECOXIB 1 Unknown 0 100 MG BID
124840022 12484002 8 C DOXAZOSIN DOXAZOSINDOXAZOSIN MESYLATE 1 Unknown 0
124840022 12484002 9 C LANSOPRAZOLE. LANSOPRAZOLE 1 Unknown 0
124840022 12484002 10 C PREDNISOLONE. PREDNISOLONE 1 Unknown 0 4 MG QD
124840022 12484002 11 C TOLTERODINE TOLTERODINE 1 Unknown 0 4 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124840022 12484002 3 Rheumatoid arthritis
124840022 12484002 4 Rheumatoid arthritis
124840022 12484002 5 Osteopenia
124840022 12484002 6 Hypertension
124840022 12484002 7 Rheumatoid arthritis
124840022 12484002 8 Hypertension
124840022 12484002 9 Prophylaxis against gastrointestinal ulcer
124840022 12484002 10 Rheumatoid arthritis

Outcome of event

Event ID CASEID OUTC COD
124840022 12484002 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124840022 12484002 Anxiety
124840022 12484002 Arthralgia
124840022 12484002 Atrial fibrillation
124840022 12484002 Blood pressure increased
124840022 12484002 Cardiac failure
124840022 12484002 Diarrhoea
124840022 12484002 Heart rate irregular
124840022 12484002 Injection site rash
124840022 12484002 Joint dislocation
124840022 12484002 Osteoarthritis
124840022 12484002 Palpitations
124840022 12484002 Rash
124840022 12484002 Rheumatoid arthritis
124840022 12484002 Sluggishness

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124840022 12484002 1 20141210 0
124840022 12484002 3 20150602 0
124840022 12484002 4 20150602 20160204 0
124840022 12484002 5 2010 0
124840022 12484002 6 2010 0
124840022 12484002 7 1996 0
124840022 12484002 8 2011 0
124840022 12484002 9 2000 0
124840022 12484002 10 199609 0